Developing non-invasive neurostimulation devices for various disorders.
Industry: Health Care
Latest Trade: $2.81 +0.10 (+3.9%)
First Day Return: -45.8%
Return from IPO: -34.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/04/2022 |
Offer Price | $4.15 |
Price Range $6.00 - $7.00 | |
Offer Shares (mm) | 2.3 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/15/2022 |
Offer Price | $4.15 |
Price Range $6.00 - $7.00 | |
Offer Shares (mm) | 2.3 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Maxim Group LLC |
Company Data | |
---|---|
Headquarters | Houston, TX, United States |
Founded | 2010 |
Employees at IPO | 3 |
Website www.nexalin.com |